LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.44 | 771.67 | 3218 | 4738 | 0.6791 | 0.7252 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.44 | 771.67 | 3896 | 4738 | 0.8222 | 0.8559 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.67 | 771.67 | 3462 | 5155 | 0.6715 | 0.7295 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.67 | 771.67 | 4183 | 5155 | 0.8113 | 0.8531 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.89 | 771.67 | 3751 | 5541 | 0.6769 | 0.7436 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.89 | 771.67 | 4394 | 5541 | 0.7929 | 0.8433 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.11 | 771.67 | 3986 | 5941 | 0.6709 | 0.7465 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.11 | 771.67 | 4768 | 5941 | 0.8025 | 0.8560 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.33 | 771.67 | 4169 | 6392 | 0.6522 | 0.7385 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.33 | 771.67 | 5065 | 6392 | 0.7923 | 0.8531 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.55 | 771.67 | 4375 | 6829 | 0.6406 | 0.7360 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.55 | 771.67 | 5227 | 6829 | 0.7653 | 0.8370 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 771.67 | 4682 | 7256 | 0.6452 | 0.7465 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 771.67 | 5731 | 7256 | 0.7898 | 0.8592 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.99 | 771.67 | 4853 | 7690 | 0.6311 | 0.7408 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.99 | 771.67 | 6007 | 7690 | 0.7811 | 0.8565 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.21 | 771.67 | 5047 | 8085 | 0.6242 | 0.7404 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.21 | 771.67 | 6309 | 8085 | 0.7803 | 0.8588 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.44 | 771.67 | 5307 | 8530 | 0.6221 | 0.7441 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.44 | 771.67 | 6598 | 8530 | 0.7735 | 0.8572 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.66 | 771.67 | 5519 | 8978 | 0.6147 | 0.7432 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.66 | 771.67 | 6957 | 8978 | 0.7749 | 0.8610 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.88 | 771.67 | 5647 | 9447 | 0.5978 | 0.7346 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.88 | 771.67 | 7221 | 9447 | 0.7644 | 0.8567 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.10 | 771.67 | 5818 | 9800 | 0.5937 | 0.7349 | MN20160304_L01 | C03 |